相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fatty Acid Synthase Inhibitor TVB-2640 Reduces Hepatic de Novo Lipogenesis in Males With Metabolic Abnormalities
Majid M. Syed-Abdul et al.
HEPATOLOGY (2020)
Recent development in acetyl-CoA carboxylase inhibitors and their potential as novel drugs
Xin Wu et al.
FUTURE MEDICINAL CHEMISTRY (2020)
Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
Gordon Smith et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Liver-Targeting Acetyl-CoA Carboxylase Inhibitor (PF-05221304): A Three-Part Randomized Phase 1 Study
Arthur Bergman et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2020)
Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation
Jamie Bates et al.
JOURNAL OF HEPATOLOGY (2020)
De novo lipogenesis is essential for platelet production in humans
Kenneth L. Kelly et al.
NATURE METABOLISM (2020)
Human sebum requires de novo lipogenesis, which is increased in acne vulgaris and suppressed by acetyl-CoA carboxylase inhibition
William P. Esler et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Dose-dependent quantitative effects of acute fructose administration on hepatic de novo lipogenesis in healthy humans
Carine Beysen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2018)
Acetyl-CoA carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis
Eric J. Lawitz et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents
Leigh Goedeke et al.
HEPATOLOGY (2018)
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
Rohit Loomba et al.
GASTROENTEROLOGY (2018)
Acetyl-Coenzyme A Carboxylase Inhibition Reduces De Novo Lipogenesis in Overweight Male Subjects: A Randomized, Double-Blind, Crossover Study
Kathryn Stiede et al.
HEPATOLOGY (2017)
Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation
Chai-Wan Kim et al.
CELL METABOLISM (2017)
Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis
Janki Patel et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2016)
Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
Jennifer E. Lambert et al.
GASTROENTEROLOGY (2014)
Augmented hepatic Toll-like receptors by fatty acids trigger the pro-inflammatory state of non-alcoholic fatty liver disease in mice
Koji Sawada et al.
HEPATOLOGY RESEARCH (2014)
De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells
Luciana Berod et al.
NATURE MEDICINE (2014)
Hepatic Lipotoxicity and the Pathogenesis of Nonalcoholic Steatohepatitis: the Central Role of Nontriglyceride Fatty Acid Metabolites
Brent A. Neuschwander-Tetri
HEPATOLOGY (2010)
分享论文
